Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
Budget 2023
Budget 2023
you are here: HomeNewsIndia

Cipla seeks DCGI nod to import Moderna's COVID-19 vaccine

DCGI is likely to take up the application soon and may even grant permission to import the COVID-19 vaccine today.

June 29, 2021 / 12:24 PM IST
The two-shot Moderna regime is around 90 percent effective against symptomatic COVID-19 and 95 percent effective against severe disease. Source: Reuters

The two-shot Moderna regime is around 90 percent effective against symptomatic COVID-19 and 95 percent effective against severe disease. Source: Reuters

Pharma major Cipla has filed an application with the Drugs Controller General of India seeking permission to import Moderna's COVID-19 vaccine in India.

The firm submitted its application to the drugs regulator on June 28, sources told CNBC TV-18.

Track this LIVE blog for latest updates on coronavirus pandemic

People aware of the development also said that DCGI is likely to take up the application soon and may even grant permission to import the COVID-19 vaccine today.